Encorium to sell US and Finnish units
CRO Encorium has unveiled plans to sell both its US business and its Finnish subsidiary Encorium Oy just weeks after posting a gloomy set of Q1 financials dominated by a 15 per cent drop in net revenues.
CRO Encorium has unveiled plans to sell both its US business and its Finnish subsidiary Encorium Oy just weeks after posting a gloomy set of Q1 financials dominated by a 15 per cent drop in net revenues.
Sanofi-aventis is has made its largest ever investment in its vaccine capacity, using €350m ($479m) to construct a dengue fever vaccine manufacturing plant in France.
PDI posted a larger operating loss in Q1 2009 than in the previous year, with the company blaming the decline on the expiration, termination and postponement of contracts.
Outsourcing-Pharma provides its latest round up of movements in the pharmaceutical outsourcing sector, including appointments at WuXi and OmniComm.
ExcellGene’s OrbShake 250L mammalian cell culture bioreactor has equalled biomass productivity and oxygenation levels previously only achieved by traditional stirred tank systems.